Teladoc Health
TDOC
178 hedge funds and large institutions have $2.17B invested in Teladoc Health in 2017 Q3 according to their latest regulatory filings, with 37 funds opening new positions, 88 increasing their positions, 27 reducing their positions, and 23 closing their positions.
226% more repeat investments, than reductions
Existing positions increased: 88 | Existing positions reduced: 27
61% more first-time investments, than exits
New positions opened: 37 | Existing positions closed: 23
10.59% more ownership
Funds ownership: 104.74% → 115.34% (+11%)
9% more capital invested
Capital invested by funds: $1.99B → $2.17B (+$177M)
7% more funds holding
Funds holding: 166 → 178 (+12)
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
49% less call options, than puts
Call options by funds: $7.18M | Put options by funds: $14.2M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$50.1M |
| 2 |
BAMCO Inc
New York
|
+$42.1M |
| 3 |
AllianceBernstein
Nashville,
Tennessee
|
+$35.1M |
| 4 |
Victory Capital Management
San Antonio,
Texas
|
+$35M |
| 5 |
Jennison Associates
New York
|
+$33.2M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Capital World Investors
Los Angeles,
California
|
-$112M |
| 2 |
Tiger Global Management
New York
|
-$75.4M |
| 3 |
CAM
Cortina Asset Management
Milwaukee,
Wisconsin
|
-$24.9M |
| 4 |
Wellington Management Group
Boston,
Massachusetts
|
-$12.6M |
| 5 |
MGM
Miura Global Management
New York
|
-$12.1M |
TDOC Hedge Fund Activity: Q3 2017 in Review
178 of the 4,022 institutional investors tracked by Wall St. Rank reported a position in Teladoc Health (TDOC) for Q3 2017, worth a combined $2.17B — up 8.9% from $1.99B a quarter earlier.
Buyers outnumbered sellers: 37 funds opened new TDOC positions and 23 closed out — a net gain of 14 holders — while 88 added to existing stakes and 27 trimmed.
The largest buyer was T. Rowe Price Associates, adding an estimated $50.1M. The largest seller was Capital World Investors, cutting an estimated $112M.
- 178 institutional investors held Teladoc Health (TDOC) as of Q3 2017, up from 166 in Q2 2017.
- Funds reported $2.17B of Teladoc Health stock for Q3 2017, up 8.9% quarter-over-quarter.
- 37 funds opened new Teladoc Health positions in Q3 2017 and 23 closed out, a net change of +14 holders.
- The largest Teladoc Health buyer in Q3 2017 was T. Rowe Price Associates, an estimated $50.1M added.
- The largest Teladoc Health seller in Q3 2017 was Capital World Investors, an estimated $112M sold.
Based on aggregated 13F filings for Q3 2017.